EXTRAWELL PHAR: Interim Report 2023/24

Hong Kong Stock ExchangeDec 18, 2023 03:30 ET · Announcements

Extrawell Pharmaceutical Swings to Fiscal H1 Loss on Fair Value Losses

Extrawell Pharmaceutical Holdings (HKG:0858) swung to an attributable loss of HK$237.7 million, or HK$0.0995 per share, in the fiscal first half, from a profit of HK$45.8 million, or HK$0.0192 per sha

MT NewswiresNov 30, 2023 02:16 ET

EXTRAWELL PHAR: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023

Hong Kong Stock ExchangeNov 29, 2023 08:40 ET · Announcements

Extrawell Pharmaceutical: Change in Fair Value of Financial Assets Weighed on Results

Extrawell Pharmaceutical: Change in Fair Value of Financial Assets Weighed on Results

Dow JonesNov 12, 2023 17:06 ET

Extrawell Pharmaceutical: 1H Loss Likely Between HK$235.0M to HK$240.0M Vs. HK$46.0M Profit Year Ago

Extrawell Pharmaceutical: 1H Loss Likely Between HK$235.0M to HK$240.0M Vs. HK$46.0M Profit Year Ago

Dow JonesNov 12, 2023 17:05 ET

Extrawell Pharmaceutical Expects to Swing to Loss for 1H Ended September

Extrawell Pharmaceutical Expects to Swing to Loss for 1H Ended September

Dow JonesNov 12, 2023 17:04 ET